Company / R&D per Share
Cytokinetics R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$3463.91
FY2025
5-year range
$1.89 / $3463.91
FY2021-FY2025
Trend
+103629.0%
vs FY2024
Sector context
#1 of 208
Health Care
What the data says
R&D per Share changed +103629% YoY in FY2025, a notable deviation from the 9-year average annual change of +11526%.
Based on SEC 10-K filings.
3463.91 in FY2025 with a 5-year CAGR of +379.6%. Ranks 1st among 208 companies in Health Care.
Improved from $3.48 to $3463.91 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +968.5%
- 5-Year CAGR
- +379.6%
- 10-Year CAGR
- -
Sector benchmark
Top 0% in Health CareTop 0% of 208This company $3463.91 Sector average $28.82
▼
+11919.8% above sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 103629.0% year-over-year.
- Ranks #1 out of 208 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -3.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3463.91 | +103629.0% |
| FY2024 | $3.34 | -4.1% |
| FY2023 | $3.48 | +22.6% |
| FY2022 | $2.84 | +50.6% |
| FY2021 | $1.89 | +38.2% |
| FY2020 | $1.37 | -6.2% |
| FY2019 | $1.46 | -10.7% |
| FY2018 | $1.63 | -2.7% |
| FY2017 | $1.67 | +13.6% |
| FY2016 | $1.47 | +25.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026